InvestSMART

The Hydration Pharmaceuticals Company Limited (ASX: HPC) - Announcements

- Current share price for HPC : $0.003

ASX company news and announcements for The Hydration Pharmaceuticals Company Limited (HPC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All The Hydration Pharmaceuticals Company Limited (HPC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than The Hydration Pharmaceuticals Company Limited (HPC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for The Hydration Pharmaceuticals Company Limited (HPC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$2 Change of Director's Interest Notice 27 Mar 2023 12:06PM $0.076 $0.003 fallen by 96.05%
$2 Q1 FY2023 Trading Update 23 Mar 2023 8:42AM $0.069 $0.003 fallen by 95.65%
$2 Change of Director's Interest Notice 9 Mar 2023 11:01AM $0.069 $0.003 fallen by 95.65%
$2 Summary of Financial Results for the year ended 31 Dec 2022 28 Feb 2023 8:45AM $0.070 $0.003 fallen by 95.71%
$2 FY22 Appendix 4E 28 Feb 2023 8:34AM $0.070 $0.003 fallen by 95.71%
$2 Notification of AGM Date 21 Feb 2023 2:33PM $0.068 $0.003 fallen by 95.59%
$2 Record monthly sales in January 13 Feb 2023 8:50AM $0.081 $0.003 fallen by 96.30%
$2 Appointment of Company Secretary 8 Feb 2023 5:36PM $0.095 $0.003 fallen by 96.84%
$2 Investor Presentation 6 Feb 2023 10:15AM $0.103 $0.003 fallen by 97.07%
$2 Q4 FY22 Quarterly Activities Report (App 4C) 31 Jan 2023 11:09AM $0.105 $0.003 fallen by 97.14%
$2 Change of Director's Interest Notice (Appendix 3Y) 29 Dec 2022 10:18AM $0.090 $0.003 fallen by 96.67%
$2 HPC achieves milestone annual revenue through Amazon USA 23 Dec 2022 9:10AM $0.090 $0.003 fallen by 96.67%
$2 Change in substantial holding 13 Dec 2022 6:40PM $0.100 $0.003 fallen by 97%
$2 Change in substantial holding 7 Dec 2022 5:36PM $0.115 $0.003 fallen by 97.39%
$2 Application for quotation of securities - HPC 5 Dec 2022 12:05PM $0.125 $0.003 fallen by 97.60%
$2 Upcoming Release of Shares from Escrow 2 Dec 2022 5:42PM $0.125 $0.003 fallen by 97.60%
$2 Launch of co-branded product with ambassador Shay Mitchell 2 Dec 2022 9:23AM $0.120 $0.003 fallen by 97.50%
$2 Upcoming Release of Shares from Escrow 25 Nov 2022 9:05AM $0.120 $0.003 fallen by 97.50%
$2 HPC streamlines US manufacturing and achieves strong sales 15 Nov 2022 8:46AM $0.120 $0.003 fallen by 97.50%
$2 Notification regarding unquoted securities - HPC 10 Nov 2022 5:11PM $0.110 $0.003 fallen by 97.27%
$2 First tranche draw-down of secured loan facility completed 10 Nov 2022 4:57PM $0.110 $0.003 fallen by 97.27%
$2 Q3 FY22 Quarterly Activities Report (App 4C) 31 Oct 2022 10:35AM $0.165 $0.003 fallen by 98.18%
$2 Investor Presentation 21 Oct 2022 8:49AM $0.155 $0.003 fallen by 98.06%
$2 Proposed issue of securities - HPC 17 Oct 2022 9:10AM $0.110 $0.003 fallen by 97.27%
$2 $12m Loan Facility Secured to Capitalise on Recent Growth 17 Oct 2022 8:44AM $0.110 $0.003 fallen by 97.27%

201 - 225 of 285 results

Page 9 of 12

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.